BATS | ETF
The fund generally will invest at least 80% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index.
The index is designed to measure the performance of equity securities of small-capitalization companies in the equity market in India.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| XTSLA | BlackRock Cash Funds Treasury SL Agency | 3.04% | ||
| INR | INR CASH | 2.73% | ||
| COFORGE | Coforge Ltd | Technology | Information Technology Services | 1.78% |
| COFORGE | Coforge Limited | Technology | Information Technology Services | 1.60% |
| MFSL | Max Financial Services Ltd | Financial Services | Insurance - Life | 1.32% |
| FORTIS | Fortis Healthcare Limited | Healthcare | Medical Care Facilities | 1.26% |
| MFSL | Max Financial Services Limited | Financial Services | Insurance - Life | 1.20% |
| FORTIS | FORTIS HEALTHCARE LTD. | Healthcare | Medical Care Facilities | 1.13% |
| GVT&D | GE Vernova T&D India Limited | Industrials | Specialty Industrial Machinery | 1.07% |
| FEDERALBNK | The Federal Bank Limited | Financial Services | Banks - Regional | 1.05% |
| EMBASSY | EMBASSY OFFICE PARKS REIT UNITS | 0.98% | ||
| EMBASSY | Embassy Office Parks REIT | Real Estate | REIT - Office | 0.96% |
| PAYTM | One 97 Communications Limited | Technology | Software - Infrastructure | 0.90% |
| LAURUSLABS | Laurus Labs Limited | Healthcare | Drug Manufacturers - Specialty & Generic | 0.89% |
| GVT&D | GE Vernova T&D India Ltd | 0.88% | ||
| GLENMARK | Glenmark Pharmaceuticals Limited | Healthcare | Drug Manufacturers - Specialty & Generic | 0.85% |
| PAYTM | One 97 Communications Limited | Technology | Software - Infrastructure | 0.77% |
| LAURUSLABS | Laurus Labs Ltd | Healthcare | Drug Manufacturers - Specialty & Generic | 0.73% |
| DELHIVERY | Delhivery Limited | Industrials | Integrated Freight & Logistics | 0.71% |
| GLENMARK | GLENMARK PHARMACEUTICALS LTD. | Healthcare | Drug Manufacturers - Specialty & Generic | 0.71% |